Please wait
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
August 12, 2024
Accession Number:
0000950170-24-094668
Submission Type:
POS AM
CIK:
0001008848
Company Name:
Acorda Therapeutics, Inc.
File Number:
333-235929